Picture of Bausch + Lomb logo

BLCO — Bausch + Lomb News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Brief: Bausch + Lomb Receives FDA Approval For Envista Envy Full Range Of Vision Intraocular Lens

Oct 14 (Reuters) - Bausch + Lomb Corp  BLCO.TO :
    * BAUSCH + LOMB RECEIVES FDA APPROVAL FOR ENVISTA® ENVY™
FULL
RANGE OF VISION INTRAOCULAR LENS
    * BAUSCH + LOMB RECEIVES FDA APPROVAL FOR ENVISTA® ENVY™
FULL
RANGE OF VISION INTRAOCULAR LENS
    * BAUSCH + LOMB CORP - ENVISTA ENVY IOLS AVAILABLE IN U.S.
ON
LIMITED BASIS IN COMING WEEKS
    * BAUSCH + LOMB: ENVISTA ENVY IOLS WILL BE COMMERCIALLY
AVAILABLE
IN U.S. MORE BROADLY IN 2025

Source text for Eikon:  ID:nBw4rYjdba 
Further company coverage:  BLCO.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Bausch + Lomb

See all news